Resmed (RSMDF) Income from Continuing Operations (2009 - 2026)

Resmed (RSMDF) has reported Income from Continuing Operations for 18 consecutive years, with $383.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income from Continuing Operations rose 0.98% year-over-year to $383.4 million; the trailing twelve-month figure through Jun 2026 stood at $1.5 billion (up 8.75% YoY), and the FY2026 full-year result was $1.5 billion, up 8.75% from the prior year.
• Income from Continuing Operations fell to $383.4 million in Q2 2026 per RSMDF's latest filing, from $398.7 million in the prior quarter.
• Across five years, Income from Continuing Operations topped out at $398.7 million in Q1 2026 and bottomed at $179.0 million in Q1 2022.
• Historically, Income from Continuing Operations has averaged $289.8 million across 5 years, with a median of $296.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations surged 328.1% in 2022, then dropped 7.16% in 2023.
• Over 5 years, Income from Continuing Operations stood at $224.9 million in 2022, then fell by 7.16% to $208.8 million in 2023, then surged by 65.05% to $344.6 million in 2024, then gained by 13.92% to $392.6 million in 2025, then fell by 2.33% to $383.4 million in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered $383.4 million, $398.7 million, and $392.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.